Skip to main content

Precipio ICE-COLD PCR Kit for Sanger Sequencing

Precipio has launched a second new version of its ICE-COLD PCR enrichment kit for use in Sanger Sequencing platforms. The multiplex panel allows identification of resistance mutations in the blood of patients with non-small cell lung cancer. Adaptation of the kit for Sanger sequencing is part of a larger effort by Precipio to modify its technology to be platform-agnostic, the company said. At approximately $150 per test, Precipio believes that its technology offers significant savings compared to competing assays for the same liquid biopsy application.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.